- Home
- ARQT vs NAC Comparison
ARQT vs NAC Comparison
Compare ARQT & NAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- NAC
- Stock Information
- Founded
- ARQT 2016
- NAC 1998
- Country
- ARQT United States
- NAC France
- Employees
- ARQT N/A
- NAC N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- NAC Investment Managers
- Sector
- ARQT Health Care
- NAC Finance
- Exchange
- ARQT Nasdaq
- NAC Nasdaq
- Market Cap
- ARQT 1.7B
- NAC 1.6B
- IPO Year
- ARQT 2020
- NAC N/A
- Fundamental
- Price
- ARQT $13.04
- NAC $10.93
- Analyst Decision
- ARQT Strong Buy
- NAC
- Analyst Count
- ARQT 6
- NAC 0
- Target Price
- ARQT $18.80
- NAC N/A
- AVG Volume (30 Days)
- ARQT 2.1M
- NAC 307.3K
- Earning Date
- ARQT 05-06-2025
- NAC 01-01-0001
- Dividend Yield
- ARQT N/A
- NAC 4.33%
- EPS Growth
- ARQT N/A
- NAC N/A
- EPS
- ARQT N/A
- NAC N/A
- Revenue
- ARQT $212,819,000.00
- NAC N/A
- Revenue This Year
- ARQT $61.15
- NAC N/A
- Revenue Next Year
- ARQT $37.98
- NAC N/A
- P/E Ratio
- ARQT N/A
- NAC N/A
- Revenue Growth
- ARQT 100.03
- NAC N/A
- 52 Week Low
- ARQT $6.99
- NAC $9.32
- 52 Week High
- ARQT $17.75
- NAC $11.21
- Technical
- Relative Strength Index (RSI)
- ARQT 40.51
- NAC 53.51
- Support Level
- ARQT $13.27
- NAC $10.69
- Resistance Level
- ARQT $14.30
- NAC $11.01
- Average True Range (ATR)
- ARQT 0.71
- NAC 0.09
- MACD
- ARQT -0.07
- NAC 0.00
- Stochastic Oscillator
- ARQT 10.94
- NAC 66.67
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About NAC Nuveen California Quality Municipal Income Fund
Nuveen California Quality Municipal Income Fund is a diversified closed-end management investment company. Its objective is to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal and California state income taxes. It invests majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.